baber/WOPTO huggingface dataset:
Patent JP-2023546913-A (JP)
Title: 積層構造
IPC: B32B27/00
Filed: 2021-10-14
Abstract: テープおよび成型部品を含む積層構造が提供される。テープは、第１の表面および反対側の第２の表面を有する基材を含み、第１の接着剤コーティングが基材の第１の表面上に配置されている。成型部品は、テープの第１の接着剤コーティングに隣接して位置付けられ、第１の接着剤コーティングに結合されており、成型部品は液晶ポリマーを含有するポリマー組成物を含む。テープと成型部品の間の剥離強度は、ＡＳＴＭ Ｄ３１６７－１０（２０１７）に従って決定される２．５４ｃｍ当たり約０．２５重量ｋｇ（１インチ当たり約０．５５重量ポンド）以上である。【選択図】図１
Patent JP-2024500285-A (JP)
Title: Ｅｎｐｐ１欠損症及びａｂｃｃ６欠損症の治療
IPC: A61K38/46
Filed: 2021-11-19
Abstract: 本開示は、特に、乳児の全身性動脈石灰化（ＧＡＣＩ）、常染色体劣性低リン血症性くる病２（ＡＲＨＲ２）、及び対象における軟部組織の異所性石灰化に関与する疾患又は障害などの病的石灰化、ＥＮＰＰ１欠損症、ＡＢＣＣ６欠損症から生じる他の疾患の治療など、ＥＮＰＰ１欠損症のインビボ治療のためのＥＮＰＰ１薬剤の特定の用量を提供する。
Patent JP-2023553800-A (JP)
Title: カソード活物質の多段階製造方法、及びカソード活物質
IPC: H01M4/525
Filed: 2021-11-10
Abstract: 本発明は、電極活物質を製造する方法に関し、ここで、前記方法が、以下の工程：（ａ）水酸化物ＴＭ（ＯＨ）２、又は少なくとも１種の酸化物ＴＭＯ、又は少なくとも１種のＴＭのオキシ水酸化物、又は上記の少なくとも２種の組み合わせを提供する工程であって、ＴＭが、１種以上の金属であり、少なくとも９７モル％のＮｉ、及び任意に合計で３モル％以下の、Ａｌ、Ｔｉ、Ｚｒ、Ｖ、Ｃｏ、Ｚｎ、Ｂａ及びＭｎから選択される少なくとも１種の金属を含有する、工程と、（ｂ）前記水酸化物ＴＭ（ＯＨ）２、又は酸化物ＴＭＯ、又はＴＭのオキシ水酸化物、又は組み合わせを、リチウム源及びＭｇ源と混合する工程であって、（Ｌｉ＋Ｍｇ）のモル量がＴＭの７５～９５モル％に相当する、工程と、（ｃ）工程（ｂ）から得られる混合物を４５０～６５０℃の範囲の温度で熱処理して、それによって中間体を得る工程と、（ｄ）工程（ｃ）からの中間体を、Ｌｉ源、及びＡｌ、Ｚｒ、Ｃｏ、Ｍｎ、Ｎｂ、Ｔａ、Ｍｏ及びＷから選択される金属Ｍ１の少なくとも１種の化合物と混合する工程と、（ｅ）工程（ｄ）から得られる混合物を５００～８５０℃の範囲の温度で熱処理する工程とを含む。
Patent JP-2024501654-A (JP)
Title: 荷電粒子光学デバイス
IPC: H01J37/244
Filed: 2021-12-15
Abstract: 本発明は、荷電粒子サブビームをサブビーム経路に沿ってサンプルまで加速させることと、二次荷電粒子を検出器アレイからはじくことと、主に荷電粒子を検出するためのモード及び主に二次粒子を検出するためのモード間で切り替わり得るデバイス及び検出器を提供することとを含む、後方散乱荷電粒子を検出するための様々な技術を提供する。【選択図】 図３
Patent JP-2024500870-A (JP)
Title: 二官能性線状融合コラーゲン局在化免疫調節分子およびその方法
IPC: C07K19/00
Filed: 2021-12-17
Abstract: ＩＬ－２；ＩＬ－１２、コラーゲン結合ドメイン、および線状ポリペプチドスペーサーを含む免疫調節融合タンパク質、それを作製および使用する方法が本明細書に開示される。本明細書に開示される免疫調節融合タンパク質は、がんを処置するのに有用である。本明細書に記載されるのは、がんを処置するための化合物、組成物、および方法である。化合物は、ＩＬ－２、ＩＬ－１２、コラーゲン結合ドメイン、および線状ポリペプチドスペーサーの各々を含む融合タンパク質を含む。
Patent JP-2024501986-A (JP)
Title: ３次元顔再構築の方法、３次元顔再構築の装置、デバイスおよび記憶媒体
IPC: G06T1/00
Filed: 2021-12-28
Abstract: ３次元顔再構築の方法、３次元顔再構築の装置、デバイスおよび記憶媒体を開示する。当該方法は、予め構築された教師ネットワークモデルによって３次元顔再構築における現在の動画フレームの定常状態再構築パラメータを推定したことに応答して、教師ネットワークモデルに対して蒸留を行なった後に得られた生徒ネットワークモデルに現在の動画フレームを入力することにより、３次元顔再構築における現在の動画フレームの働的再構築パラメータを推定することと、定常状態再構築パラメータと働的再構築パラメータを予め構築された３次元モーファブルモデルに入力することにより、現在の動画フレームに対応する３次元顔を再構築することと、を含む。
Patent JP-2024503709-A (JP)
Title: データ伝送方法及び装置
IPC: H04W72/0457
Filed: 2021-01-15
Abstract: 本願はデータ伝送方法及び装置を提供する。方法は、端末デバイスについて条件付きの候補プライマリセカンダリセルグループセルＰＳＣｅｌｌ追加又は変更を構成する段階；マスターネットワークデバイスによって、候補ＰＳＣｅｌｌが属するネットワークデバイスに向けられた早期データ伝送を実行し、例えば、端末デバイスが候補ＰＳＣｅｌｌにアクセスする前に、候補ＰＳＣｅｌｌが属するネットワークデバイスへデータパケットを送信する段階、ここで、データパケットの形式はパケットデータコンバージェンスプロトコルのプロトコルデータユニットであり、データパケットは、ＭＮ終端セカンダリセルグループベアラ上のデータパケット、及び／又は、ＭＮ終端スプリットベアラ上のデータパケットを含む、を備え得る。このように、端末デバイスが候補ネットワークデバイスにアクセスした後に、候補ネットワークデバイスは、転送されたデータを端末デバイスへ送信し、データ伝送遅延を低減し得る。加えて、本願は、ＭＮ終端セカンダリセルグループベアラ上のデータパケット、及び／又は、ＭＮ終端スプリットベアラ上のデータパケットの早期データ転送をサポートし得、その結果、これらのベアラ上のデータの伝送遅延を低減できる。
Patent MX-2007000049-A (MX)
Title: Dust free absorbent packaging materials.
Inventor: HAHN HANS-ULRICH
IPC: B65D81/00
Filed: 2007-01-08
Abstract: A liquid-absorbing, impact-absorbing packaging container for protecting packaged items such as bottled liquids, while providing absorbency in the event of a liquid spill. The container material is created from a mixture of an inorganic liquid-absorbing agent such as vermiculite, and a cellulosic material such as paper pulp, which mixture is then formed into a container material, for packaging an article such as a glass bottle. The containers and container materials of this invention are substantially free of dust and/or loose particles.
Patent MX-2007000617-A (MX)
Title: Electronic device.
Inventor: GOTO TEIYU
IPC: G06F1/16
Filed: 2006-05-12
Abstract: An electronic device such as an entertainment device having an appearance shape with a functionality improved compared to conventional ones. The electronic device comprises a main case (10) having a generally elliptically cylindrical shape, so disposed that its longitudinal direction is generally horizontal to the installation surface, and having medium insertion slots (14, 26, 28, 30) into which portable information storage media such as an optical disk are inserted and a base (52) provided under the main case (10) and having a generally boxy shape.
Patent MX-2007005533-A (MX)
Title: Method and apparatus for reducing the processing rate of a chip-level equalization receiver.
Inventor: PAN KYLE JUNG-LIN
IPC: H04B1/00
Filed: 2005-10-19
Abstract: A method and apparatus for reducing the processing rate when performing chip-levelequalization (CLE) in a code division multiple access (CDMA) receiver whichincludes an equalizer filter. Signals received by at least one antenna of thereceiver are sampled at M times the chip rate. Each sample stream is split intoM sample data streams at the chip rate. Multipath combining is preferably performedon each split sample data stream. The sample data streams are then combined intoone combined sample data stream at the chip rate. The equalizer filter performsequalization on the combined sample stream at the chip rate. Filter coefficientsare adjusted by adding a correction term to the filter coefficients utilizedby the equalizer filter for a previous iteration.
Patent MX-2007006661-A (MX)
Title: Polyester/polyamide blend having improved flavor retaining property and clarity.
Inventor: GAMBLE BENJAMIN BRADFORD
IPC: C08K3/08
Filed: 2005-11-28
Abstract: This invention relates to a polyester/polyamide blend having an excellent gas barrier property. More particularly, the present invention relates to combinations of a polyethylene terephthalate polymer and a polyamide polymer having an excellent gas barrier property and short oxygen scavenging induction periods, where the polyamide polymer has a C:A terminal group concentration ratio of 2:1 or more and a C + A terminal group concentration of at least 0.17 meq/g of polyamide polymer, wherein C represents a cumulative total of a terminal carboxyl group concentration and a terminal hydrocarbyl group concentration expressed in meq/g of polyamide, and A represents a terminal amine group concentration expressed in meq/g of polyamide.
Patent MX-2007010638-A (MX)
Title: Methods and compositons for modified release of nutritional supplements.
Inventor: MCANALLEY BILL H
IPC: A23L33/15
Filed: 2005-03-03
Abstract: The present invention relates to the modified release of nutritional supplements by combining one or more isolated and purified long-chain polysaccharides and one or more nutritional supplements selected from anti-oxidants, vitamins, minerals, amino acids, nucleic acids, mixtures and combinations thereof, wherein the supplement is compressed at a pressure greater that 100 psi.
Patent MX-2007011834-A (MX)
Title: Benzimidazole derivative and use as angiotensin ii antagonist.
Inventor: KUROITA TAKANOBU
IPC: C07D413/10
Filed: 2006-03-29
Abstract: The present invention provides (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate represented by the formula: which has superior properties as a pharmaceutical agent, a salt thereof, a crystal thereof, a pharmaceutical agent containing the compound, and the like.
Patent MX-2007013368-A (MX)
Title: Filter arrangement for a range hood.
Inventor: FEISTHAMMEL EGON
IPC: B01D45/08
Filed: 2006-02-16
Abstract: The invention relates to a filter arrangement for a range hood (2), which is used for separating particles and/or liquid drops from an air flow (W) penetrating the filter arrangement (1). Said filter arrangement comprises at least two shells (11, 12, 25) that lie inside each other. The inventive filter arrangement is characterized in that the shells (11, 12, 25) are removably connected to one another such that producing, handling, and cleaning the filter arrangement (1) is simplified.
Patent MX-2007014380-A (MX)
Title: Imidazoquinolines as lipid kinase inhibitors.
Inventor: GARCIA-ECHEVERRIA CARLOS
IPC: A61P29/00
Filed: 2006-05-18
Abstract: The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.
Patent MX-2007015150-A (MX)
Title: Novel piperidine derivative.
Inventor: WADA TOSHIHIRO
IPC: A61P27/00
Filed: 2006-05-29
Abstract: Disclosed is a substance having an antagonistic effect on the binding of histamine to a histamine H3 receptor or an inhibitory effect on the activity which a histamine H3 receptor constantly exhibits. A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: (I) wherein R<sup>1</sup> represents a phenyl group which may be substituted or the like and R<sup>2</sup> represents a cyano group which may be substituted or the like, or R<sup>1</sup> and R<sup>2</sup> together form an aliphatic hetetocyclic ring which may be substituted; R<sup>3</sup> represents a group represented by the formula (II-1) below; and all of X<sub>1</sub> to X<sub>4</sub> represent a carbon atom or the like: (II-1) where R<sup>4</sup> and R<sup>5</sup> represent a lower alkyl group or the like; and m1 represents an integer of 2 to 4.
Patent MX-2007015439-A (MX)
Title: Device specific content indexing for optimized device operation.
Inventor: SADOVSKY VLADIMIR
IPC: G06F7/00
Filed: 2006-04-26
Abstract: Generation of an index database that is customized for a specific responder device using device parameters of the responder device is provided. The index database is generated on a device other than the responder device. In accordance with one method, an indication of a selection of objects is received. Device parameters of the responder device are also accessed. An index database is generated for the selection of objects using the device parameters of the responder device. The index database may then be transferred to the responder device.
Patent MX-2008003038-A (MX)
Title: Pyrrolopyridine derivatives and use of same as ppar receptor modulators.
Inventor: LEGENDRE CHRISTIANE
IPC: C07D471/04
Filed: 2006-08-31
Abstract: The invention relates to pyrrolopyridine derivative compounds having general formula (I) as defined in the claims and to the pharmaceutically-acceptable addition salts thereof. The invention also relates to the method of preparing the aforementioned compounds, to pharmaceutical compositions containing same and to the use thereof as a pharmacologically-active substance, for example in the treatment of hypertriglyceridaemias, hyperlipidemias, hypercholesterolemias, diabetes, endothelial dysfunction, cardiovascular and inflammatory diseases and neurodegeneration.
Patent MX-2008012015-A (MX)
Title: Crystalline forms of n- {2-tert -butyl -1- [ (4,4- dif luorocyclohexyl) methyl] -lh-benzimidazol-5- yl}ethanesulfonamide salts.
Inventor: BOHLIN MARTIN
IPC: C07D235/08
Filed: 2007-03-22
Abstract: A salt of the compound<i> N-</i>{2<i>-tert</i>-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1 <i>H</i>-benzimidazol-5-yl}ethanesulfonamide, which is an ethanesulphonic acid salt, a sulphuric acid salt, an ethane disulphonic acid salt, a hydrochloric acid salt, a hydrobromic acid salt, a phosphoric acid salt, an acetic acid salt, a fumaric acid salt, a maleic acid salt, a tartaric acid salt, a citric acid salt, a methanesulphonic acid salt, or a p-toluenesulphonic acid salt of said compound.
Patent MX-2008013051-A (MX)
Title: Extended life led fixture.
Inventor: RIES II JACK LEIGHTON
IPC: H05B44/00
Filed: 2008-10-09
Abstract: An LED fixture includes multiple LED drivers and multiple LED lamps so that the lifetime of the fixture is a multiple of the lifetime of a conventional fixture that uses only a single LED driver. A distributed controller activates and deactivates the LED drivers so that the different LED lamps are driven sequentially. An optional multi-lamp LED driver concurrently drives multiple LED lamps that have been previously driven by the LED drivers.
Patent MX-2008013688-A (MX)
Title: Patch and uses thereof.
Inventor: DUPONT CHRISTOPHE
IPC: B29D7/01
Filed: 2007-04-24
Abstract: A patch comprising a support having electrostatic properties is provided wherein a periphery of the support is coated with an adhesive material, and all or part of the non-adhesive surface of the support is covered with at least one biologically active substance in the form of particles that is adhered to the non-adhesive part of the support by electrostatic forces.
Patent MX-2008016016-A (MX)
Title: Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders.
Inventor: KOU JIM H
IPC: A61K47/38
Filed: 2007-06-12
Abstract: The present invention provides compositions as well as kits and methods based on a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 that are useful for treating inflammatory disorders.
Patent MX-2008016032-A (MX)
Title: Method and device for installing cables and jackets in a non-inspectable pipe.
Inventor: WECKER GERARD
IPC: G02B6/50
Filed: 2007-01-05
Abstract: The present invention relates to a method of installing a flexible elongate body (1) such as a cable inside a pipe (2), in particular a non-inspectable pipe, wherein said elongate body is held against a wall (21) of said pipe using discrete supporting elements (3, 3') by means of which the elongate body can be pressed against the inner wall of the pipe. In this method, prior to inserting said elongate body (1) into said pipe (2), a plurality of said discrete supporting elements (3, 3') are fastened along the length of said elongate body; and the supporting elements are flexurally stressed and held under stress by means of a locking element (4). Said elongate body is then introduced into said pipe between at least two openings which allow access to said pipe, and said elongate body is pressed against the wall (21) of said pipe by withdrawing or rupturing said locking element (4) that stresses each discrete supporting element, causing said supporting element and said elongate body to be pressed against the wall of the pipe. A robotic device (5) for implementing the method of the invention is also described.
Patent MX-2009005552-A (MX)
Title: Hinged lid container with outer shell.
Inventor: BOURGOIN PHILIPPE
IPC: B65D85/10
Filed: 2007-11-22
Abstract: The present invention relates to a A container (1) comprising an outer shell (30), wherein the outer shell (30) comprises a outer shell front wall (32), a outer shell rear wall (35), left (33) and right (34) outer shell side walls and an outer shell stopper flap (37), and wherein the outer shell (30) at least partially embraces an inner slide (10, 20), wherein the inner slide (10, 12) comprises a box portion (10), wherein the box portion (10) of the inner slide (10, 20) comprises a box bottom wall (11), a box front wall (12) and a box rear wall (15) and a inner slide stopper flap (17), wherein the inner slide (10, 20) further comprises a lid portion (20), wherein the lid portion (20) of the inner slide (10, 20) comprises a lid top wall (26), and wherein the lid portion (20) of the inner slide (10, 20) is hinged to the box portion (10) of the inner slide (10, 20) at the box rear wall (15) and wherein the outer shell stopper flap (37) and the inner slide stopper flap (17) interact with each other and limit the movement between the outer shell (30) and the inner slide (10, 20) when opening the container (1), wherein the box front wall (12) comprises the inner slide stopper flap (17) and the outer shell front wall (32) comprises the outer shell stopper flap (37).
Patent MX-2009007783-A (MX)
Title: Safety line anchor.
Inventor: CAYLOR GERALD L
IPC: A62B35/00
Filed: 2009-07-21
Abstract: An anchor for securing a safety line to a container having an opening defined by an upstanding rim comprises a bar which is longer than the opening is wide. A pair of hooks are connected to the anchor bar by hook mounts. The hooks open downward toward ends of the anchor bar such that the rim of the access opening may be secured between each hook and an associated end of the anchor bar. A mounting tab is connected to an end of each hook below a hook bend. A safety line connector may be connected to either tab through a hole formed therein. The mounting tabs project outward to permit connection of a safety line thereto even when the access opening is covered. A third mounting tab, to which a safety line connector may be connected, is pivotally secured around the anchor bar.
Patent MX-2009010631-A (MX)
Title: Multiphase personal care composition comprising a structuring system that comprises an associative polymer, a low hlb emulsifier and an electrolyte.
Inventor: WEI KARL SHIQING
IPC: A61K8/81
Filed: 2008-03-28
Abstract: The present invention relates to a multiphase personal care composition. The multiphase personal care composition comprises an aqueous structured surfactant phase, a structuring system, and a benefit phase. The aqueous structured surfactant phase comprises from about 5% to about 16%, by weight of the multiphase personal care composition, of a lathering surfactant selected from the group consisting of anionic surfactants, nonionic surfactants, amphoteric surfactants, cationic surfactants or mixtures thereof and a structuring system. The structuring system comprises a non-ionic emulsifier having an HLB of from about 1.4 to about 13; about 0.05% to about 5%, by weight of the multiphase personal care composition, of an associative polymer; and an electrolyte. The benefit phase comprises from about 5% to about 30%, by weight of the multiphase personal care composition, of hydrophobic benefit material.
Patent MX-2009012215-A (MX)
Title: Telecommunication assembly with an inner frame and an outer frame.
Inventor: SCHLUETER DIETRICH
IPC: H04Q1/14
Filed: 2008-04-30
Abstract: Telecommunication assembly 1 comprising termination modules 21 having electrical contacts for connecting wires, an outer frame 2 and at least one inner frame 4 for carrying a predetermined number of termination modules 21, the inner frame 4 is detachably fixed at the outer frame 2 wherein thin inner and the outer frame enclose a space.
Patent MX-2009013663-A (MX)
Title: Solubilized formulation of docetaxel without tween 80.
Inventor: PALEPU NAGESWARA R
IPC: A61K31/337
Filed: 2008-06-19
Abstract: Lyophilizates containing docetaxel and the use thereof in preparing concentrated liquid formulations, and ready to use formulations for injection, as well as such concentrates and ready to use formulations themselves are disclosed in which Tween surfactants are avoided so that hypersensitivity reactions to Tween surfactants can be avoided and docetaxel can be administered at higher doses and/or for longer periods of time and/or for additional treatment cycles.
Patent MX-2010001987-A (MX)
Title: A method of extending the dose range of vitamin d compounds.
Inventor: CLAGETT-DAME MARGARET
IPC: A61K31/663
Filed: 2008-08-19
Abstract: Inhibitors of bone calcium resorption are administered, and calcium intake in the subject's diet is restricted, to allow high doses of vitamin D compounds or mimetics to be given with the intent of treating diseases such as metabolic bone diseases, hyperparathyroidism, cancer, psoriasis, and autoimmune diseases without the dangers of calcification of kidney, heart, and aorta. Inhibitors of bone calcium resorption include the bis-phosphonates, OPG (osteoprotegerin) or the soluble RANKL (receptor activator of NF-kappaB ligand) receptor known as sRANK (soluble RANK which is the protein expressed by the NF-kappaB gene), and function to block the availability of calcium from bone thereby preventing hypercalcemia and the resulting calcification of soft tissues. Thus, high doses of lÎ+-,25-dihydroxyvitamin D3 (1,25-(OH)2D3), its analogs, prodrugs, or mimetics can be utilized to treat the target disease with minimal risk to a patient. Specifically, alendronate is shown to block the bone calcium mobilization activity of both 1,25-(OH)2D3 and its very potent analog, 2-methylene-19-nor-(20S)-lÎ+-,25-dihydroxyvitamin D3, as long as the subject being treated is on a low calcium diet.
Patent MX-2010002594-A (MX)
Title: Protective shields and covers and methods for installing the same.
Inventor: CLODIUS-TALMADGE JULIE
IPC: A41D13/00
Filed: 2008-09-06
Abstract: Protective shields with and without retaining wings and shield cover for protecting the vulva and labia minora of a female. The protective shield is shaped to conform to the outer shape of the labia minora and may include retaining wings which hold the shield in place. An outer cover may be installed on the shield for protective and ornamental purposes.
Patent MX-2010003840-A (MX)
Title: Process for preparing polyether alcohols from unsaturated starters with active hydrogen atoms.
Inventor: ANNEN ULRICH
IPC: C08G65/00
Filed: 2007-10-25
Abstract: A process for preparing polyether alcohols by reacting at least one alkylene oxide with at least one unsaturated starter having at least one active hydrogen atom per molecule under basic catalysis, which comprises performing the alkoxylation in at least two stages, the alkoxylation of the starter(s) being performed in stage (I) with a maximum of 10 mol of alkylene oxide per mole of starter with a catalyst concentration of not more than 0.0085 mol of basic catalyst per mole, and, in stage (II) and any subsequent stages, reacting the alkoxylated starter(s) from stage (I) with further alkylene oxide at a catalyst concentration of at least 0.010 mol of basic catalyst per mole of starter.
Patent MX-2010007266-A (MX)
Title: (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol- vitamin d analogs.
Inventor: PLUM LORI A
IPC: C07C401/00
Filed: 2008-12-24
Abstract: This invention discloses (20S)-23,23-difIuoro-2-methylene-19-nor-bishomopregnacalciferol -vitamin D analogs, and specifically (20S)-23,23-difluoro- 1 Î±- hydroxy-2-methylene-19-nor-bishomopregnacalciferol, and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.
Patent MX-2010007923-A (MX)
Title: Crystalline form of abacavir that is essentially free of solvent.
Inventor: BERENGUER MAIMO RAMON
IPC: A61K31/52
Filed: 2009-01-21
Abstract: Crystalline form of abacavir that is essentially free of solvent of formula (I), in particular crystalline Form I, and its preparation process which comprises the following steps: a) crystallizing abacavir from a solution of said compound in a (C1-C4)-alcohol, dichloromethane, acetonitrile/water, or mixtures thereof; b) isolating the crystalline form of abacavir that appears in the prior step; and c) removing the solvent from the crystalline form of abacavir thus obtained. Crystalline Form I can also be obtained by dispersion of abacavir in acetonitrile. The crystalline form of abacavir that is essentially free of solvent is useful for the preparation of pharmaceutical compositions for use in the treatment and/or prophylaxis of HIV infections.
Patent MX-2010008137-A (MX)
Title: Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof.
Inventor: GOEBEL WERNER
IPC: C12R1/42
Filed: 2009-01-29
Abstract: The invention relates to an non-pathogenic and/or attenuated bacterium which is capable of inducing apoptosis in macrophages. Also disclosed are a process of manufacturing thereof and uses of such bacterium as a medicament.